1.
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
by DeFronzo, R. A
Diabetologia, 2010-04-02, Vol.53 (7), p.1270-1287
2.
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
by GASTALDELLI, A
Diabetologia, 2004, Vol.47 (1), p.31-39
3.
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation i...
by Coletta, D. K
Diabetologia, 2009-01-24, Vol.52 (4), p.723-732
4.
Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes
by CIVITARESE, A. E
Diabetologia, 2004, Vol.47 (5), p.816-820
5.
Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes
by DeFronzo, R. A
The journal of clinical endocrinology and metabolism, 2012-05, Vol.97 (5), p.1615-1622
6.
Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism
by Norton, L
Diabetologia, 2011-09-07, Vol.54 (12), p.3132-3142
7.
Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants
by Abdul-Ghani, M. A
Diabetologia, 2009-01-30, Vol.52 (4), p.574-582
8.
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus
by BAJAJ, M
Diabetologia, 2007, Vol.50 (8), p.1723-1731
9.
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
by MIYAZAKI, Y
Diabetologia, 2001, Vol.44 (12), p.2210-2219
10.
Lentivirus shRNA Grb10 targeting the pancreas induces apoptosis and improved glucose tolerance due to decreased plasma glucagon levels
by Doiron, B
Diabetologia, 2012-01-07, Vol.55 (3), p.719-728
11.
Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism...
by Monroy, A
Diabetologia, 2009-07-25, Vol.52 (10), p.2169-2181
12.
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
by DeFronzo, R. A
Diabetologia, 2009-12-10, Vol.53 (3), p.435-445
13.
Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects
by Cersosimo, E
The journal of clinical endocrinology and metabolism, 2011-06, Vol.96 (6), p.1763-1770
14.
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance
by FERRANNINI, E
Diabetologia, 2003, Vol.46 (9), p.1211-1219
15.
Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus : a balanced overview
by DEFRONZO, R. A
Diabetologia, 1992, Vol.35 (4), p.389-397
16.
Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans
by RICHARDSON, D. K
Diabetologia, 2006, Vol.49 (10), p.2317-2328
17.
Insulin resistance and coronary artery disease
by BRESSLER, P
Diabetologia, 1996, Vol.39 (11), p.1345-1350
18.
Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes
by CUSI, K
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (3), p.1410-1417
19.
To: Godsland IF, Jeffs JA, Johnston DG (2004) loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166
by Abdul-Ghani, M A
Diabetologia, 2005-10, Vol.48 (10), p.2187-2188
20.
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
by DEFRONZO, R. A
The journal of clinical endocrinology and metabolism, 1991, Vol.73 (6), p.1294-1301
